Samples should be collected shortly before chemotherapy or at least two weeks after the previous treatment

Collect M - Th only before 2 pm

8.5 mL cfDNA collection tubes x2

Collection tubes included in the FoundationOne CDx kit

Immediately following collection, mix by inverting 5 - 10 times to prevent clotting

• Do not spin
• Submit original tubes

Collection tubes from the FoundationOne CDx collection kit

• Completed FoundationOne requisition included in the kit
• The health care provider will fill out the test requisition form including patient insurance information. Testing should NOT be billed to our Allina Health facility.
• For Medicare patients, the provider will also need to have the Medicare ABN Form filled out.

Ambient (strict) - 14 days

Refrigerated – NO

Frozen – NO

Ship same day as collection if possible

• Not collected in kit tubes
• Specimens refrigerated or frozen

FoundationOne Liquid CDx is a qualitative next generation sequencing based in vitro diagnostic test that uses targeted high throughput hybridization-based capture technology to detect and report substitutions,insertions and deletions (indels) in 311 genes, rearrangements in four (4) genes, and copy number alterations in three (3) genes. FoundationOne Liquid CDx utilizes circulating cell-free DNA (cfDNA) isolated from plasma derived from anti-coagulated peripheral whole blood of cancer patients collected in FoundationOne Liquid CDx cfDNA blood collection tubes included in the FoundationOne Liquid CDx Blood Sample Collection Kit. The test is intended to be used as a companion diagnostic to identify patients who may benefit from treatment with the targeted therapies.

See report

Includes guideline-recommended genes and biomarkers to help guide therapy selection and identify clinical trial options for patients with solid tumors.

Cancer type: Solid Tumors